Budas, Sham Sha Shahara .
HRN: 23-72-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2024
AMPICILLIN 1GM (VIAL)
10/12/2024
10/18/2024
IVT
400mg
Q6
Urti
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes